COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,794 Articles (22,527 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 1657: Articles 16561-16570  | Next

Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection
Perez-Gomez, A., Vitalle, J., Gasca-Capote, M. d. C., Gutierrez-Valencia, A., Trujillo-Rodriguez, M., Serna-Gallego, A., Munoz-Muela, E., Jimenez-Leon, M. d. l. R., Rafii-El-Idrissi Benhnia, M., Rivas-Jeremias, I., Sotomayor, C., Roca-Oporto, C., Espinosa, N., Infante-Dominguez, C., Crespo-Rivas, J. C., Fernandez-Villar, A., Perez-Gonzalez, A., Lopez-Cortes, L. F., Poveda, E., Ruiz-Mateos, E.
10.1101/2021.03.18.436001 — Posted: 2021-03-19
A combined strategy to detect plasma samples reliably with high anti-SARS-CoV-2 neutralizing antibody titers in routine laboratories
Fischer, B., Lichtenberg, C., Mueller, L., Timm, J., Fischer, J., Knabbe, C.
10.1101/2021.03.15.21253588 — Posted: 2021-03-19
The B1.351 and P.1 variants extend SARS-CoV-2 host range to mice
Montagutelli, X., Prot, M., Levillayer, L., Baquero Salazar, E., Jouvion, G., Conquet, L., Donati, F., Albert, M., Gambaro, F., Behillil, S., Enouf, V., Rousset, D., Jaubert, J., Rey, F., van der Werf, S., Simon-Loriere, E.
10.1101/2021.03.18.436013 — Posted: 2021-03-18 Discussion: Onsite
Evaluation of a new spike (S) protein based commercial immunoassay for the detection of anti-SARS-CoV-2 IgG
Eberhardt, K. A., Dewald, F., Heger, E., Gieselmann, L., Vanshylla, K., Wirtz, M., Kleipass, F., Johannis, W., Schommers, P., Gruell, H., Brensing, K. A., Mueller, R.-U., Augustin, M., Lehmann, C., Koch, M., Klein, F., Di Cristanziano, V.
10.1101/2021.03.10.21253288 — Posted: 2021-03-18
Genetic variability associated with OAS1 expression in myeloid cells increases the risk of Alzheimer's disease and severe COVID-19 outcomes
Magusali, N., Graham, A. C., Piers, T. M., Panichnantakul, P., Yaman, U., Shoai, M., Reynolds, R. H., Botia, J. A., Brookes, K. J., Guetta-Baranes, T., Bellou, E., Bayram, S., Sokolova, D., Ryten, M., Sala Frigerio, C., Escott-Price, V., Morgan, K., Pocock, J. M., Hardy, J., Salih, D. A.
10.1101/2021.03.16.435702 — Posted: 2021-03-18 Discussion: Onsite
Identification of guanylyltransferase activity in the SARS-CoV-2 RNA polymerase
Walker, A. P., Fan, H., Keown, J. R., Grimes, J., Fodor, E.
10.1101/2021.03.17.435913 — Posted: 2021-03-18
A novel SARS-CoV-2 related virus with complex recombination isolated from bats in Yunnan province, China
Li, L., Wang, J., Ma, X., Li, J., Yang, X., Shi, W., Duan, Z.
10.1101/2021.03.17.435823 — Posted: 2021-03-18
Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies
Greaney, A. J., Starr, T. N., Barnes, C. O., Weisblum, Y., Schmidt, F., Caskey, M., Gaebler, C., Agudelo, M., Finkin, S., Wang, Z., Poston, D., Muecksch, F., Hatziioannou, T., Bieniasz, P. D., Robbiani, D. F., Nussenzweig, M. C., Bjorkman, P. J., Bloom, J. D.
10.1101/2021.03.17.435863 — Posted: 2021-03-18
Myocarditis in naturally infected pets with the British variant of COVID-19
Ferasin, L., Fritz, M., Ferasin, H., Becquart, P., Legros, V., Leroy, E. M.
10.1101/2021.03.18.435945 — Posted: 2021-03-18 Discussion: Onsite
A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses
Tauzin, A., Nayrac, M., Benlarbi, M., Gong, S. Y., Gasser, R., Beaudoin-Bussieres, G., Brassard, N., Laumaea, A., Vezina, D., Prevost, J., Anand, S. P., Bourassa, C., Gendron-Lepage, G., Medjahed, H., Goyette, G., Niessl, J., Tastet, O., Gokool, L., Morrisseau, C., Arlotto, P., Stamatatos, L., McGuire, A. T., Larochelle, C., Uchil, P., Lu, M., Mothes, W., De Serres, G., Moreira, S., Roger, M., Richard, J., Martel-Laferriere, V., Duerr, R., Tremblay, C., Kaufmann, D. E., Finzi, A.
10.1101/2021.03.18.435972 — Posted: 2021-03-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).